DaVita Inc.

NYSE:DVA

Medical - Care Facilities

Healthcare
$161.79 +0.77%

+$1.60 today

Market cap
$10.18B
Beta
0.91
P/E (TTM)
18.2
EPS (TTM)
$11.60
52W Low $101.00High $213.44

Volume 1.12M

Average 0.84M

DVA Net Income

Bottom-line profit after all expenses, interest, and taxes.

DaVita Inc.NYSE: DVA

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income growth accelerates

Q2 FY2026 net income of $265.4M rose 33.1% year over year, ahead of the +1.3% change in trailing-twelve-month net income. Sequentially, it rose 34.4% from the prior quarter. Over 3 fiscal years it compounded at +10.0% a year.

Context

  • Net income amounted to 5.5% of revenue in FY2025, down 1.8 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 5 analysts of $1.13B (+50.9%) for the fiscal year ending Dec 2026, a step up from the -20.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$265.4M+34.4% QoQ
Last fiscal yearDec 2025
$746.8M-20.2% YoY
LTMJun 2026
$847.48M+1.3% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+33.1%+55.8%+22.6 pp
1 year-20.2%+50.9%+71.1 pp
3-year CAGR+10.0%+25.8%+15.7 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the income statement

Latest · FY2025
746.8M USD
Year-over-year change
-20.2%
4-year CAGR
-6.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How DVA compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1.3% is the 2nd highest of 3, against a peer median of -271.5%.
  • Net income amounts to 6.0% of revenue for DVA, versus a peer median of 7.0%.
DVA Competitors
Net Income for DVA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€937.78M EUR+42.9%+13.3%4.8%
DVADaVita Inc.LTM Jun 2026$847.48M USD+1.3%+10.0%6.0%
BAXBaxter International Inc.LTM Jun 2026-$1.06B USD-585.8%—9.3%
Peer median (excluding DVA) —-271.5%+13.3%7.0%

Competitors are the stored peer set for DVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue11.62B11.61B12.14B12.82B13.64B
Cost of Revenue7.97B8.21B8.32B8.6B9.96B
Gross Profit3.65B3.4B3.82B4.22B3.68B
Gross Margin31.4%29.3%31.5%32.9%27.0%
Research & Development00000
Selling, General & Admin1.2B1.36B1.47B1.54B1.67B
Operating Expenses1.85B2.06B2.22B2.13B1.67B
Depreciation & Amortization680.62M732.6M745.44M723.86M715.35M
EBITDA2.48B2.06B2.32B2.72B2.64B
EBITDA Margin21.4%17.7%19.1%21.3%19.4%
Operating Income1.8B1.34B1.6B2.09B2.01B
Operating Margin15.5%11.5%13.2%16.3%14.7%
Interest Income00000
Interest Expense285.25M357.02M398.55M470.47M549.67M
Other Income / Expenses(278.88M)(372.78M)(425.69M)(560.09M)(663.79M)
Income Before Tax1.52B966.28M1.18B1.53B1.35B
Pre-Tax Margin13.1%8.3%9.7%11.9%9.9%
Income Tax Expense306.73M198.09M220.12M279.66M293.11M
Net Income978.45M560.4M691.54M936.34M746.8M
Net Margin8.4%4.8%5.7%7.3%5.5%
EPS (Basic)9.305.887.6211.029.72
EPS (Diluted)8.905.717.4210.739.51
Weighted Avg Shares105.23M92.99M90.79M84.99M86.1M
Weighted Avg Shares (Diluted)109.95M95.83M93.18M87.27M88.1M

DaVita Inc.

NYSE:DVA

Intrinsic Alpha fair value

Locked

Current Price

$161.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.